FDA — authorised 23 May 1990
- Application: NDA019972
- Marketing authorisation holder: NOVARTIS
- Local brand name: OCUPRESS
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 Ocupress in United States
FDA authorised Ocupress on 23 May 1990
Marketing authorisations
FDA — authorised 3 January 2000
- Application: ANDA075476
- Marketing authorisation holder: SANDOZ
- Status: approved
Ocupress in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Ocupress approved in United States?
Yes. FDA authorised it on 23 May 1990; FDA authorised it on 3 January 2000.
Who is the marketing authorisation holder for Ocupress in United States?
NOVARTIS holds the US marketing authorisation.